[Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease].

@article{Lamotte2006HealthEE,
  title={[Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease].},
  author={Mark Lamotte and Carme Pi{\~n}ol and Carlos Brotons and Lieven Annemans and Elena Guardiola and Thomas Evers and Maria Kubin},
  journal={Revista espanola de cardiologia},
  year={2006},
  volume={59 8},
  pages={807-15}
}
INTRODUCTION AND OBJECTIVES Low-dose aspirin is standard treatment for patients with a history of cardiovascular disease. Its use in primary prevention is more controversial. However, recent studies also support the use of aspirin in high-risk individuals with no history of cardiovascular disease. This study investigated the health economic implications of… CONTINUE READING